PE27799A1 - Formulaciones y formas polimorficas de desferrioxamina y su preparacion - Google Patents

Formulaciones y formas polimorficas de desferrioxamina y su preparacion

Info

Publication number
PE27799A1
PE27799A1 PE1997001097A PE00109797A PE27799A1 PE 27799 A1 PE27799 A1 PE 27799A1 PE 1997001097 A PE1997001097 A PE 1997001097A PE 00109797 A PE00109797 A PE 00109797A PE 27799 A1 PE27799 A1 PE 27799A1
Authority
PE
Peru
Prior art keywords
despherrioxamine
refers
salt
acid
crystal
Prior art date
Application number
PE1997001097A
Other languages
English (en)
Inventor
Nicholas Lowther
Joanne Nicklin
Alan Steward
Peter Hoogevest
Andre Joseph Geoffroy
Hans Hirt
Andreas Burkhard
Ian Francis Hassan
Erwin Marti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625878.5A external-priority patent/GB9625878D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE27799A1 publication Critical patent/PE27799A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA FORMULACION PARENTERAL DE LIBERACION SOSTENIDA, QUE COMPRENDE: PARTICULAS DE 5� A 10� DE UNA SAL DE DESFERRIOXAMINA-B DE UN ACIDO SULFONICO ALIFATICO DE AL MENOS 8 CARBONOS, SUSPENDIDA EN ACEITE. TAMBIEN SE REFIERE A UNA FORMA CRISTALINA DE 1-DECANSULFONATO DE DESFERRIOXAMINA DE FORMULA (I), CARACTERIZADO POR UN PUNTO DE FUSION DE 154�C A 158�C, Y POR UN PATRON DE DIFRACCION DE RAYOS X EN 2U�: 3,1 4,2 7,3 8,4 9,4 10,5 13,7 16,8 17,4 18,0 18,4 19,6 20,1 20,9 22,3 23,7 25,1 25,6. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE DICHO CRISTAL, QUE COMPRENDE: CALENTAR UNA SOLUCION DE METANOSULFONATO DE DESFERRIOXAMINA; AGREGAR UNA CANTIDAD EQUIMOLAR DE UNA SAL DE ACIDO 1-DECANSULFONICO; INDUCIR LA CRISTALIZACION CON UN CRISTAL DE SIEMBRA Y CONTINUAR AGREGANDO EL RESTO DE LA CANTIDAD EQUIMOLAR DE LA SAL DE ACIDO 1-DECANSULFONICO, OBTENIENDOSE UNA SOLUCION SATURADA EN CALIENTE DE 1-DECANSULFONATO DE DESFERRIOXAMINA EN UN SOLVENTE POLAR, A UNA TEMPERATURA ELEVADA; LA CRISTALIZACION OCURRE A UNA VELOCIDAD DE ENFRIAMIENTO DE 1�C/MINUTO. ESTE CRISTAL MAS ESTABLE, NO MOSTRARA UNA TRANSFORMACION DE ESTADO SOLIDO, INDEPENDIENTE DE LA FASE DE DISPERSION, EN LA PRODUCCION, ALMACENAMIENTO Y USO PARA EL TRATAMIENTO UNA ENFERMEDAD DE SOBRECARGA DE Fe o Al, MALARIA, ENTRE OTROS
PE1997001097A 1996-12-10 1997-12-05 Formulaciones y formas polimorficas de desferrioxamina y su preparacion PE27799A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH302496 1996-12-10
GBGB9625878.5A GB9625878D0 (en) 1996-12-12 1996-12-12 Compositions

Publications (1)

Publication Number Publication Date
PE27799A1 true PE27799A1 (es) 1999-03-18

Family

ID=25691970

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997001097A PE27799A1 (es) 1996-12-10 1997-12-05 Formulaciones y formas polimorficas de desferrioxamina y su preparacion

Country Status (15)

Country Link
EP (1) EP0944586A2 (es)
KR (1) KR20000069376A (es)
CN (1) CN1239946A (es)
AR (1) AR009655A1 (es)
AU (1) AU5983998A (es)
BR (1) BR9713570A (es)
CA (1) CA2274761A1 (es)
CO (1) CO4910160A1 (es)
CZ (1) CZ204499A3 (es)
ID (1) ID22388A (es)
IL (1) IL130203A0 (es)
PE (1) PE27799A1 (es)
PL (1) PL334316A1 (es)
TR (1) TR199901260T2 (es)
WO (1) WO1998025887A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090016517A (ko) * 1999-12-23 2009-02-13 벨루스 헬스 (인터내셔널) 리미티드 대뇌 아밀로이드 혈관병증을 조절하는 화합물 및 방법
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10223913A1 (de) * 2002-05-29 2003-12-11 Bayer Cropscience Ag Verfahren zur Herstellung spezifischer Kristallmodifikationen polymorpher Substanzen
WO2017068090A1 (en) 2015-10-23 2017-04-27 Vifor (International) Ag Novel ferroportin inhibitors
JOP20180036A1 (ar) 2017-04-18 2019-01-30 Vifor Int Ag أملاح لمثبطات فروبورتين جديدة
TW202102478A (zh) 2019-04-01 2021-01-16 瑞士商威佛(國際)股份有限公司 新穎的鐵螯合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH438351A (de) * 1959-09-25 1967-06-30 Ciba Geigy Verfahren zur Herstellung neuer Wuchsstoffe
FR1898M (fr) * 1961-04-07 1963-07-08 Ciba Geigy Nouvelle substance utilisable en thérapeutique.
GB9211779D0 (en) * 1992-06-03 1992-07-15 Ciba Geigy Ag Amine salts

Also Published As

Publication number Publication date
CA2274761A1 (en) 1998-06-18
AU5983998A (en) 1998-07-03
BR9713570A (pt) 2000-03-14
CZ204499A3 (cs) 1999-09-15
WO1998025887A2 (en) 1998-06-18
AR009655A1 (es) 2000-04-26
CO4910160A1 (es) 2000-04-24
PL334316A1 (en) 2000-02-14
ID22388A (id) 1999-10-07
IL130203A0 (en) 2000-06-01
EP0944586A2 (en) 1999-09-29
TR199901260T2 (xx) 1999-10-21
KR20000069376A (ko) 2000-11-25
WO1998025887A3 (en) 1998-08-13
CN1239946A (zh) 1999-12-29

Similar Documents

Publication Publication Date Title
CO5271720A1 (es) Proceso para fabricar selectivamente hemipentahidrato y monopentahidrato de acido 3-piridil-12hidroxi-etiliden-1, 1-bisfofosnico sodio y composicion farmacetica que las contiene
PE20020290A1 (es) Polimorfos de analogos de epotilona de formula (i)
ECSP066645A (es) Pirimidinas herbecidas
AR068527A2 (es) Un procedimiento para preparar monohidrato de bromuro de tiotropio cristalino
PE27799A1 (es) Formulaciones y formas polimorficas de desferrioxamina y su preparacion
ES2090105T3 (es) Procedimiento para purificar acidos aminometilenofosfonicos.
MX167804B (es) Estructuras microplasticas y metodo de fabricaccon
CA2088742A1 (en) Benzimidazole and imidazopyridine derivatives and their application
SU664565A3 (ru) Способ получени пиридо (1,2а) пиримидинов или их оптических изомеров
AR024222A1 (es) Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
AR008244A1 (es) Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
AR028968A1 (es) Derivados heterociclicos de la aminoalquilpiridina como psicofarmacos
PE20060170A1 (es) Nueva forma cristalina de acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo[4.3.0]nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxilico
CO4480032A1 (es) Cristales de glicosidos de espiroestanilo
AR039733A1 (es) Proceso para la obtencion de norelgestromin en distintas relaciones de los isomeros e y z
ES2193517T3 (es) Procedimiento para la cristalizacion de lactitol.
PE20000115A1 (es) Forma termodinamicamente estable del acido (r)-3-[[(4-fluorofenil)sulfonil]amino]-1,2,3,4-tetrahidro-9h-carbazol-9-propanoico (ramatroban)
JPS5922986A (ja) 蓄熱材
DK421183D0 (da) Fremgangsmade til fremstilling af alfa-aryl-alfa-pyridylalkansyrer
JPS5425168A (en) Manufacture of heat sink for semiconductor
PE20010155A1 (es) Polimorfos de un citrato de azobiciclo [2.2.2]oct-3-ilamina cristalino y sus composiciones farmaceuticas
PE20030920A1 (es) Formas cristalinas de agonistas del receptor b3-adrenergico, procedimiento para su preparacion y sus usos
JP3880677B2 (ja) 潜熱蓄熱材組成物
US2748121A (en) 6-nitroaryl derivatives of 2-amino-4-pyrimidols
JPH0157157B2 (es)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal